Stephanie Hilz

4PUBLICATIONS
59CO-AUTHORS
Molecular targetsGenomicsCancer therapy (excl. chemotherapy and radiation therapy)Microbial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Mar 12, 2025
Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samples.

Qixuan Wang, Juan Wang, Radhika Mathur

|Sep 05, 2024
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.

Komal L Jhaveri, Melissa K Accordino, Philippe L Bedard

|Sep 01, 2016
The roles of microRNAs and siRNAs in mammalian spermatogenesis.

Stephanie Hilz, Andrew J Modzelewski, Paula E Cohen

Pageof 1